LRRK2 and Parkinson disease: We have previously reported a low frequency (0.59%) of known monogenic variants in a large Swedish series of PD patients (n = 2206) screened for variants and/or duplication in SNCA and LRRK2 [35]; a subgroup of the 154 probands from the present study were included in that study [35].